SBRT vs Standard RT: Which Offers a QoL Edge in NSCLC?

Compared to hypofractionated radiotherapy, SBRT improves short-term but not long-term QoL in patients with inoperable stage I non-small cell lung cancer, new data show. Medscape Medical News

Read the full article on medscape.com